β‐Hydroxybutyrate in Cancer: From Alternative Fuel to a Context‐Dependent Metabolic Signal
The FASEB Journal · 31.10.2026 · 40 (20)
DOI: 10.1096/fj.202603664rr ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 21.10.2026. Verfasst von Qihai Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui, China. Hauptthemen laut MEDLINE: 3-Hydroxybutyric Acid, Neoplasms, Signal Transduction. Die Arbeit nennt 103 Literaturangaben. Gefördert von: The research start-up found for High-Lever Talent Recruitment of Anhui College of Traditional Chinese Medicine, the key university science research project of anhui province.
Abstract (Originalsprache)
β‐Hydroxybutyrate ( BHB ) is the primary circulating ketone body generated during fasting, prolonged exercise, carbohydrate restriction, and ketogenic diets. Beyond functioning as an alternative oxidative substrate, BHB engages in HCAR2 ‐mediated signaling, HDAC ‐related regulation, redox coupling, and lysine β‐hydroxybutyrylation, thus influencing tumor cell metabolism, chromatin state, and the tumor immune microenvironment. The biological effects of BHB in cancer exhibit high context dependency. In certain models, BHB inhibits inflammation, angiogenesis, epithelial‐mesenchymal transition, or tumor growth, while in others, it promotes metabolic adaptation, survival, metastasis, or treatment resistance. These seemingly contradictory outcomes can be elucidated through two major mechanistic switch points. The first involves tumor cell ketolytic competence: cells exhibiting effective BHB uptake, functional BDH1 – OXCT1 ‐dependent ketolysis, and preserved mitochondrial respiration may utilize BHB as an adaptive substrate under nutrient or therapeutic stress. The second concerns cellular allocation within the tumor microenvironment, determining whether BHB preferentially supports malignant cells, antitumor lymphocytes, or other immune and stromal populations. Furthermore, BHB source and treatment context further modulate these responses. Notably, ketogenic diet, direct BHB supplementation, and tumor‐intrinsic ketogenesis represent biologically distinct experimental states and should not be interpreted interchangeably. This review integrates current evidence into a source–access–interpretation framework that differentiates tumor‐adaptive, signaling‐dominant, and immune‐supportive BHB states, emphasizing priorities for causal, cell‐resolved, and biomarker‐guided investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, Anhui, China.
ORCID-Profile: Yaping Bai
Förderung
- The research start-up found for High-Lever Talent Recruitment of Anhui College of Traditional Chinese Medicine
- the key university science research project of anhui province
Zitieren
APA
Wang, Q., & Bai, Y. (2026). β‐Hydroxybutyrate in Cancer: From Alternative Fuel to a Context‐Dependent Metabolic Signal. The FASEB Journal, 40(20). https://doi.org/10.1096/fj.202603664rr
Vancouver
Wang Q, Bai Y. β‐Hydroxybutyrate in Cancer: From Alternative Fuel to a Context‐Dependent Metabolic Signal. The FASEB Journal. 2026;40(20). doi:10.1096/fj.202603664rr
BibTeX
@article{Wang2026,
author = {Wang, Qihai and Bai, Yaping},
title = {β‐Hydroxybutyrate in Cancer: From Alternative Fuel to a Context‐Dependent Metabolic Signal},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {20},
doi = {10.1096/fj.202603664rr}
}
EUVIMED